Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 2/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31654371 | 0.83 | CES1 (0.44) | ALDH1A1EGLN1FFAR3HAO1OR51E2 | |
| Pyruvate SCHEMBL4596388 | 0.80 | TDP1 (0.44) | ALDH1A1EGLN1FFAR3TDP1HAO1 | |
| Pyruvate SCHEMBL5054355 | 0.80 | ALDH1A1 (0.48) | ALDH1A1EGLN1FFAR3TDP1MGAM | |
| Hydrogen Peroxide SCHEMBL28038876 | 0.80 | — | — | |
| SCHEMBL1514891 | 0.77 | FFAR3 (0.53) | ALDH1A1EGLN1FFAR3TDP1HAO1 | |
| SCHEMBL15648054 | 0.77 | — | — | |
| SCHEMBL15355728 | 0.77 | — | — | |
| SCHEMBL24128 | 0.77 | — | — | |
| SCHEMBL27432 | 0.77 | — | — | |
| SCHEMBL120572 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12538922-B2 | Composition and methods for parasite control | PHILIP MORRIS PRODUCTS S.A. (CH) | 2026-02-03 | — | — | US | disclosed |
| CN-113491644-B | Additive composition and use of pyruvic acid or pyruvate | 株式会社爱茉莉太平洋 | 2025-01-28 | — | — | CN | disclosed |
| CN-117795049-A | Composition for removing edge bead from metal-containing resist and method for forming pattern | 三星SDI株式会社 | 2024-03-29 | — | — | CN | disclosed |
| CN-117089418-A | Substrate treatment composition and substrate treatment method using same | SK株式会社 | 2023-11-21 | — | — | CN | disclosed |
| CN-117025316-A | Substrate treatment composition and substrate treatment method using same | SK株式会社 | 2023-11-10 | — | — | CN | disclosed |
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2023-07-20 | — | — | US | disclosed |
| EP-3890833-B1 | SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE IN A NON-RACEMIC RATIO | Metys Pharmaceuticals AG (CH) | 2023-06-07 | — | — | EP | disclosed |
| EP-4172156-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | Philip Morris Products S.A. (CH) | 2023-05-03 | — | — | EP | disclosed |
| CN-115524926-A | Method for manufacturing semiconductor device | 台湾积体电路制造股份有限公司 | 2022-12-27 | — | — | CN | disclosed |
| US-20220400674-A1 | COMPOSITION AND METHODS FOR PARASITE CONTROL | PHILIP MORRIS PRODUCTS S.A. (CH) | 2022-12-22 | — | — | US | disclosed |
| US-11529342-B2 | Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2022-12-20 | — | — | US | disclosed |
| EP-3986131-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | Philip Morris Products, S.A. (CH) | 2022-04-27 | — | — | EP | disclosed |
| US-20220047548-A1 | SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-e OXOPYRROLEDIN-1-YL)BUTANAMEDE IN A NON-RACEMIC RATIO | Metys Pharmaceuticals AG (CH) | 2022-02-17 | — | — | US | disclosed |
| EP-2389187-A1 | SORBIC AND BENZOIC ACID AND DERIVATIVES THEREOF ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (US) | 2011-11-30 | — | — | EP | disclosed |
| US-8040867-B2 | Method of multi-antenna wireless data emission, emitter and receiver using the method | MITSUBISHI ELECTRIC CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| WO-2010085452-A9 | SORBIC AND BENZOIC ACID AND DERIVATIVES THEREOF ENHANCE THE ACTIVITY OF A NEUROPHARMACEUTICAL | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR - UCLA MEDICAL CENTER (US) | 2011-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225323-A1 | COMPOSITIONS AND METHODS FOR PARASITE CONTROL | TRHDE, CUTA, PIGS | ALDH1A1 2870/4885EGLN1 93/4885FFAR3 2881/4885 |
| US-12538922-B2 | Composition and methods for parasite control | CAT, CTRL, NOX1 | ALDH1A1 729/4885EGLN1 869/4885FFAR3 1769/4885 |
| US-20220400674-A1 | COMPOSITION AND METHODS FOR PARASITE CONTROL | C5, NOX5, CYCS | ALDH1A1 3497/4885EGLN1 1534/4885FFAR3 3565/4885 |
| US-20220047548-A1 | SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-e OXOPYRROLEDIN-1-YL)BUTANAMEDE IN A NON-RACEMIC RATIO | GAP43, CACNA1E, CACNA1D | ALDH1A1 2388/4885EGLN1 3731/4885FFAR3 630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.